Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Tanzania: ARVs Now for Any CD4 Count

People living with HIV would from October start anti-retroviral treatment straightaway given any CD4 cell count upon testing, the government has announced.

Published
10 hours ago
From
AllAfrica
HIV effort let down by test shortages, says WHO

A shortage of HIV testing could undermine global efforts to diagnose and treat people with the infection, warn experts from the World Health Organization.

Published
10 hours ago
From
BBC Health
Hysteria about drugs and harm minimisation. It's always the same old story

"No matter how impressive the evidence of benefits, or how weak the evidence of serious side effects or how badly a strategy is needed, new harm reduction strategies are always greeted the same way: with relentless hostility. Debates about harm reduction always follow the same pattern. Hysterical fears are confidently asserted as if proven beyond doubt while potential benefits, often based on considerable research and experience, are dismissed or ignored."

Published
23 August 2016
From
The Guardian
Bill Clinton’s valedictory for the family charity includes a farewell to AIDS health initiative

Former president Bill Clinton said Monday that he will step aside from a health-care charity he founded if Hillary Clinton is elected president, further severing ties between a potential second Clinton White House and the Clinton Foundation born of the first one.

Published
23 August 2016
From
Washington Post
Art Aids America review – gay artists channel anguish, anger and intimacy

Aids hit America’s artist community hard, and the suffering of the plague years of the 1980s is brought vividly to life in a flawed but vital exhibition at the Bronx Museum, New York.

Published
22 August 2016
From
The Guardian
German medicines watchdog rejects ‘new tenofovir’ pill

The German health technology assessment agency IQWiG has announced that it finds no advantage in Descovy, a combination pill containing a new version of the HIV

Published
22 August 2016
By
Gus Cairns
HIV prevention drug Truvada won't be subsidised in Australia

Truvada, an expensive breakthrough drug that prevents people from getting HIV won't be funded by taxpayers in Australia this year, the nation's drug funding panel has ruled. A Department of Health spokeswoman said the PBAC understood "this is an important new prevention medication for HIV", but decided the price set by the drug's sponsor, Gilead Sciences, was too high and a proposal to limit subsidy to a small subset of the "at risk" group was not feasible. "In its deliberations the PBAC indicated a substantial price reduction would be needed to make Truvada available for PrEP for the whole 'at risk' population, but noted that Truvada for PrEP could represent value for money in the broader population at a substantially lower price," the spokeswoman said.

Published
19 August 2016
From
Sydney Morning Herald
How can clinical services engage men who have sex with men in Africa?

Men who have sex with men living in African countries have an extremely high burden of HIV, Stefan Baral of Johns Hopkins University reminded delegates at the 21st International

Published
19 August 2016
By
Roger Pebody
Hillary Clinton calls out drug maker Gilead over price of hepatitis C pills

Democratic presidential nominee Hillary Clinton said Wednesday her administration will go after drug companies that charge exorbitant prices, singling out the company Gilead, whose hepatitis C drugs cost between $900 and $1,000 per pill in the United States.

Published
19 August 2016
From
UPI.com
German agency criticises European programme for speeding some drug approvals

In pointed remarks, Germany’s cost-effectiveness watchdog has criticised an effort by European regulators to accelerate approval for new medicines by limiting its requirements for evidence. The concerns raised by the agency come as regulators on both side of the Atlantic increasingly look to such approaches to get new drugs to patients with unmet medical needs. At issue is a proposal called adaptive pathways, a term used to describe a method for jumpstarting drug approvals for select patient populations. Two years ago,an EMA pilot programme was launched to compare initial data used for approval with so-called “real world” data, which is subsequently gathered after the medicines are in use.

Published
18 August 2016
From
STAT
← First12345...565Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close